Goldman Sachs’s Livent Corporation LTHM Stock Holding History

Goldman Sachs’s Portfolio LTHM Stock Details LTHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-110,000	Closed	-$1.98M	–	6021
2023 Q4	$1.98M	Hold	110,000	–	–	﹤0.01%	3935
2023 Q3	$2.03M	Buy	+110,000	New	+$2.52M	﹤0.01%	3761
2020 Q1	–	Sell	-335,000	Closed	-$2.86M	–	5637
2019 Q4	$2.86M	Hold	335,000	–	–	﹤0.01%	3395
2019 Q3	$2.24M	Hold	335,000	–	–	﹤0.01%	3458
2019 Q2	$2.32M	Buy	+335,000	New	+$3.01M	﹤0.01%	3439

Other funds holding LTHM

MIM

MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

MLICM

Metropolitan Life Insurance Company (MetLife) New York $328M AUM 9.77% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

ACA

American Capital Advisory Ketchum, Idaho $275M AUM 22.21% 1-Year Est. Return

Goldman Sachs's LTHM Position: Q1 2024 in Review

Goldman Sachs sold out of Livent Corporation (LTHM) in Q1 2024, closing a stake of 899,981 shares — an estimated $16.2M sold.

Goldman Sachs first reported a position in LTHM in Q4 2018 and held it in 21 quarters. The position peaked at $34M in Q2 2023. 6 funds tracked by Wall St. Rank hold LTHM as of Q1 2024.

Goldman Sachs reported no remaining Livent Corporation position as of Q1 2024 after selling out during the quarter.
Goldman Sachs sold 899,981 Livent Corporation shares in Q1 2024, an estimated $16.2M.
Goldman Sachs first reported a position in Livent Corporation in Q4 2018 and held it in 21 quarters.
Goldman Sachs's Livent Corporation position peaked at $34M in Q2 2023.
6 funds tracked by Wall St. Rank held Livent Corporation as of Q1 2024.

Based on Goldman Sachs's 13F filing for Q1 2024, filed 15 May 2024.